chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Tachycardia, Vulvovaginal rash
Clinical narrative: Itchiness; Rash on foot and rash spread to her legs; Rash on her foot very red; Swelling of legs; Vulval rash; Tachycardia; Nausea; Fever; Tiredness; Lymph nodes of her armpit became swollen; Pain on her bones(big bones like her hips); Chills; Feeling cold; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BONE PAIN (Pain on her bones(big bones like her hips)), PRURITUS (Itchiness), RASH (Rash on foot and rash spread to her legs), ERYTHEMA (Rash on her foot very red) and PERIPHERAL SWELLING (Swelling of legs) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039b21a and 037a21b) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced BONE PAIN (Pain on her bones(big bones like her hips)), FEELING COLD (Feeling cold) and CHILLS (Chills). On 23-Apr-2021, the patient experienced PRURITUS (Itchiness), RASH (Rash on foot and rash spread to her legs), ERYTHEMA (Rash on her foot very red), PERIPHERAL SWELLING (Swelling of legs), VULVOVAGINAL RASH (Vulval rash), TACHYCARDIA (Tachycardia), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Tiredness) and LYMPHADENOPATHY (Lymph nodes of her armpit became swollen). On 28-Apr-2021, BONE PAIN (Pain on her bones(big bones like her hips)), PRURITUS (Itchiness), RASH (Rash on foot and rash spread to her legs), ERYTHEMA (Rash on her foot very red), PERIPHERAL SWELLING (Swelling of legs), VULVOVAGINAL RASH (Vulval rash), FEELING COLD (Feeling cold), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Tiredness) and CHILLS (Chills) had resolved. At the time of the report, TACHYCARDIA (Tachycardia) and LYMPHADENOPATHY (Lymph nodes of her armpit became swollen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Blood pressure measurement: (High) High blood pressure.         Concomitant product use was not provided by the reporter. Treatment details included a self prescribed medication Benadryl cream & 2 Benadryl pills 25mg.Patient  called ER and went to hospital where she was given a cocktail:intravenous serum hexadrol 0.6mg benadryl advil 0.5mg pepsid 20mg 2ml Toradol, To be taken when she got back home:steroids prednisone 20mg twice a day and naproxen.  Action taken with mRNA-1273 in response to events were not applicable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pain in extremity
Clinical narrative: Arm still sore / hand is hurting for 3 weeks now; Arm is hard; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm still sore / hand is hurting for 3 weeks now) and INDURATION (Arm is hard) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     Medical history has not been reported.  Concomitant products included ADALIMUMAB (HUMIRA), METHOTREXATE SODIUM (METOTREXATE), ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN C [ASCORBIC ACID], LEVOTHYROXINE and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm still sore / hand is hurting for 3 weeks now) and INDURATION (Arm is hard). At the time of the report, PAIN IN EXTREMITY (Arm still sore / hand is hurting for 3 weeks now) and INDURATION (Arm is hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medication included cholesterol medication.  Patient did not seek any treatment.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore). At the time of the report, PAIN IN EXTREMITY (arm was a little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications not reported. Med Info Agent: Staff Customer called to report that him and his wife had received the first dose of the Moderna COVID-19 Vaccine on Monday (26APR2021). Customer states his arm was a little sore but his wife was ok. But that night, customer reports that his wife woke up in the middle of the night and was not feeling good. Customer reports that shoulder of the injection site down to the elbows and wrist became sore. The next day, 27APR2021, customer states that his wife had said that it felt like she had an electrical current running through her head which felt like her whole brain was being shorted out.  No additional information could be obtained regarding the husband's case.; Sender's Comments:  MOD-2021-100555:Wife's case
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain in extremity, Thirst
Clinical narrative: Body aches; Exhaustion; pain in arm; Extremely thirsty; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Body aches), FATIGUE (Exhaustion), PAIN IN EXTREMITY (pain in arm) and THIRST (Extremely thirsty) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body aches), FATIGUE (Exhaustion), PAIN IN EXTREMITY (pain in arm) and THIRST (Extremely thirsty). At the time of the report, MYALGIA (Body aches), FATIGUE (Exhaustion), PAIN IN EXTREMITY (pain in arm) and THIRST (Extremely thirsty) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment was reported by the patient.  The patient reported that the symptoms were there for 48 hours.   This case was linked to US-MODERNATX, INC.-MOD-2021-101758 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101758:
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: dizziness\gotten worse; vertigo\gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness\gotten worse) and VERTIGO (vertigo\gotten worse) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness\gotten worse) and VERTIGO (vertigo\gotten worse). At the time of the report, DIZZINESS (dizziness\gotten worse) and VERTIGO (vertigo\gotten worse) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment was administered.   This case was linked to MOD-2021-100603 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Pain at injection site; Mild headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (Mild headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included QUETIAPINE, LEVOTHYROXINE, LORAZEPAM, IMIPRAMINE, VENLAFAXINE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (Mild headaches). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (Mild headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site induration, Vaccination site swelling
Clinical narrative: Sore arm; Felt like there was knot inside; Left arm started to swell at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE INDURATION (Felt like there was knot inside) and VACCINATION SITE SWELLING (Left arm started to swell at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), VACCINATION SITE INDURATION (Felt like there was knot inside) and VACCINATION SITE SWELLING (Left arm started to swell at the injection site). The patient was treated with PARACETAMOL at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown and VACCINATION SITE INDURATION (Felt like there was knot inside) and VACCINATION SITE SWELLING (Left arm started to swell at the injection site) had resolved.            Other treatment details included rubbed alcohol on it. Concomitant medication were not provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: cannot lay on my arm; arm is sore and hurts; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (cannot lay on my arm) and PAIN IN EXTREMITY (arm is sore and hurts) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included METFORMIN, GLIMEPIRIDE and DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA) for Diabetes, LOSARTAN for Hypertension.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced LIMB DISCOMFORT (cannot lay on my arm) and PAIN IN EXTREMITY (arm is sore and hurts). At the time of the report, LIMB DISCOMFORT (cannot lay on my arm) and PAIN IN EXTREMITY (arm is sore and hurts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that no medications were taken to help with the symptoms.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Body ache; Fever; Chills; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Body ache), PYREXIA (Fever) and CHILLS (Chills) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C2 1A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021 at 10:00 PM, the patient experienced PAIN (Body ache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PAIN (Body ache), PYREXIA (Fever) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of arthralgia (shoulder still hurts) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011M20A) for COVID-19 immunization. No medical history reported. On Feb 4, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 4, 2021, patient experienced arthralgia (shoulder still hurts). The patient treated with cortisone for shoulder pain, 1 dosage form. At the time of the report, arthralgia (shoulder still hurts) outcome: unknown. mRNA-1273 (Moderna COVID-19 vaccine): dosing remained unchanged. Concomitant medications included steroids.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site reaction, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE SWELLING (Swelling on injection site arm) and VACCINATION SITE ERYTHEMA (Redness on injection site arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to sulfa) and Asthma.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE SWELLING (Swelling on injection site arm) and VACCINATION SITE ERYTHEMA (Redness on injection site arm). At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE SWELLING (Swelling on injection site arm) and VACCINATION SITE ERYTHEMA (Redness on injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: General pain; Headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (General pain) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PAIN (General pain) and HEADACHE (Headache). At the time of the report, PAIN (General pain) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Inflammation, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Acne; Right lower thigh is protruding; Right lower thigh/knee pain; Feels heavier" in right lower thigh, about the knee; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right lower thigh/knee pain), MUSCULOSKELETAL STIFFNESS (Feels heavier" in right lower thigh, about the knee), ACNE (Acne) and INFLAMMATION (Right lower thigh is protruding) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 036A21A) for COVID-19 vaccination.     No medical history provided by Reporter.  Concomitant products included LOSARTAN for Blood pressure, ATORVASTATIN for Cholesterol, VITAMIN C [ASCORBIC ACID], VITAMIN B NOS, VITAMIN B3, MAGNESIUM CHLORIDE;ZINC, BIOTIN and CALCIUM for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (Right lower thigh/knee pain), MUSCULOSKELETAL STIFFNESS (Feels heavier" in right lower thigh, about the knee) and INFLAMMATION (Right lower thigh is protruding). On an unknown date, the patient experienced ACNE (Acne). At the time of the report, PAIN IN EXTREMITY (Right lower thigh/knee pain), MUSCULOSKELETAL STIFFNESS (Feels heavier" in right lower thigh, about the knee), ACNE (Acne) and INFLAMMATION (Right lower thigh is protruding) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided by Reporter.   This case was linked to MOD-2021-053137 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: No new information was provided. On 01-Jun-2021: No significant information was received. On 04-Jun-2021: Non significant followup On 04-Jun-2021: Added concomitant medications and updated events outcome
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: General body ache; Fatigue; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (General body ache) and FATIGUE (Fatigue) in a 36-year-old male patient who received mRNA-1273 for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced MYALGIA (General body ache) and FATIGUE (Fatigue). On 01-Apr-2021, MYALGIA (General body ache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-102006 (E2B Linked Report).; Sender's Comments:  MOD-2021-102006:Second Dose
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Depressed mood, Hypersomnia, Illness
Clinical narrative: was feeling down; has no appetite; fever; chills; extremely ill; slept over 36 hours; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (extremely ill), HYPERSOMNIA (slept over 36 hours), DEPRESSED MOOD (was feeling down), DECREASED APPETITE (has no appetite) and PYREXIA (fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced ILLNESS (extremely ill), HYPERSOMNIA (slept over 36 hours), DECREASED APPETITE (has no appetite), PYREXIA (fever) and CHILLS (chills). On 01-May-2021, the patient experienced DEPRESSED MOOD (was feeling down). At the time of the report, ILLNESS (extremely ill), HYPERSOMNIA (slept over 36 hours), DEPRESSED MOOD (was feeling down), DECREASED APPETITE (has no appetite), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.  Patient is concomitantly taking thyroid and water pill.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: was feeling down; has no appetite; fever; chills; extremely ill; slept over 36 hours; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (extremely ill), HYPERSOMNIA (slept over 36 hours), DEPRESSED MOOD (was feeling down), DECREASED APPETITE (has no appetite) and PYREXIA (fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced ILLNESS (extremely ill), HYPERSOMNIA (slept over 36 hours), DECREASED APPETITE (has no appetite), PYREXIA (fever) and CHILLS (chills). On 01-May-2021, the patient experienced DEPRESSED MOOD (was feeling down). At the time of the report, ILLNESS (extremely ill), HYPERSOMNIA (slept over 36 hours), DEPRESSED MOOD (was feeling down), DECREASED APPETITE (has no appetite), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.  Patient is concomitantly taking thyroid and water pill.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over"; patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over"; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") and RASH (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concomitant products included DESLORATADINE (ARIA DES) for an unknown indication.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Apr-2021, the patient experienced RASH PRURITIC (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") and RASH (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over"). The patient was treated with PREDNISONE for Rash, at a dose of 40 mg and TRIAMCINOLONE ACETONIDE for Rash, at a dose of 0.1 %. At the time of the report, RASH PRURITIC (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") and RASH (patient states the rash is itchy and on their buttocks, thighs, breast, back, stomach "just all over") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: This spontaneous case reported by a non-healthcare professional, describes the occurrence of injection site erythema (redness at the injection site), injection site swelling (swelling at the injection site) and injection site induration (hardness at the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 046B21A) for COVID-19 immunization. No medical history reported. On Apr 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 23, 2021, patient experienced  injection site erythema (redness at the injection site), injection site swelling (swelling at the injection site) and injection site induration (hardness at the injection site). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, injection site erythema (redness at the injection site), injection site swelling (swelling at the injection site) and injection site induration (hardness at the injection site) outcome: unknown.  The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Hypopnoea, Nasal discomfort, Pruritus, Skin induration
Clinical narrative: Itchiness in legs and back with no hives; itchiness in left arm at injection site; ear started to itch; nose hairs stood up; Breathing got a little shallow; back of neck had raised skin; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (ear started to itch), NASAL DISCOMFORT (nose hairs stood up), HYPOPNOEA (Breathing got a little shallow), SKIN INDURATION (back of neck had raised skin) and PRURITUS (Itchiness in legs and back with no hives) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included TRAZODONE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), MELATONIN and LORAZEPAM for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced EAR DISCOMFORT (ear started to itch) and NASAL DISCOMFORT (nose hairs stood up). 24-Apr-2021, the patient experienced HYPOPNOEA (Breathing got a little shallow), SKIN INDURATION (back of neck had raised skin) and VACCINATION SITE PRURITUS (itchiness in left arm at injection site). On an unknown date, the patient experienced PRURITUS (Itchiness in legs and back with no hives). At the time of the report, EAR DISCOMFORT (ear started to itch), NASAL DISCOMFORT (nose hairs stood up), HYPOPNOEA (Breathing got a little shallow), SKIN INDURATION (back of neck had raised skin), PRURITUS (Itchiness in legs and back with no hives) and VACCINATION SITE PRURITUS (itchiness in left arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was given for symptoms.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Itchiness in legs and back with no hives; itchiness in left arm at injection site; ear started to itch; nose hairs stood up; Breathing got a little shallow; back of neck had raised skin; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (ear started to itch), NASAL DISCOMFORT (nose hairs stood up), HYPOPNOEA (Breathing got a little shallow), SKIN INDURATION (back of neck had raised skin) and PRURITUS (Itchiness in legs and back with no hives) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included TRAZODONE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), MELATONIN and LORAZEPAM for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced EAR DISCOMFORT (ear started to itch) and NASAL DISCOMFORT (nose hairs stood up). 24-Apr-2021, the patient experienced HYPOPNOEA (Breathing got a little shallow), SKIN INDURATION (back of neck had raised skin) and VACCINATION SITE PRURITUS (itchiness in left arm at injection site). On an unknown date, the patient experienced PRURITUS (Itchiness in legs and back with no hives). At the time of the report, EAR DISCOMFORT (ear started to itch), NASAL DISCOMFORT (nose hairs stood up), HYPOPNOEA (Breathing got a little shallow), SKIN INDURATION (back of neck had raised skin), PRURITUS (Itchiness in legs and back with no hives) and VACCINATION SITE PRURITUS (itchiness in left arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was given for symptoms.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain, Vaccination site rash, Vaccination site swelling
Clinical narrative: rash is now spreading, swollen, painful and burning.; rash is now spreading, swollen, painful and burning; Small rash; General Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (rash is now spreading, swollen, painful and burning), VACCINATION SITE RASH (Small rash), VACCINATION SITE SWELLING (rash is now spreading, swollen, painful and burning.) and MYALGIA (General Soreness) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010B21A) for COVID-19 vaccination.     No Medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (MICROGESTIN FE) for Birth control.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced MYALGIA (General Soreness). On 25-Apr-2021, the patient experienced VACCINATION SITE RASH (Small rash). On an unknown date, the patient experienced VACCINATION SITE PAIN (rash is now spreading, swollen, painful and burning) and VACCINATION SITE SWELLING (rash is now spreading, swollen, painful and burning.). At the time of the report, VACCINATION SITE PAIN (rash is now spreading, swollen, painful and burning), VACCINATION SITE RASH (Small rash), VACCINATION SITE SWELLING (rash is now spreading, swollen, painful and burning.) and MYALGIA (General Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Per patient the rash is now spreading, swollen, painful and burning. Patient is using cold compress to alleviate her symptoms.  Patient does not have a primary care physician but she provided consent to contact the vaccination facility. Patient provided consent for safety team to contact her on her phone number
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash, Skin burning sensation, Urticaria
Clinical narrative: Little welts breaking out on the back of her neck; She has one right in the center of her throat and a few in the middle of her chest; Itching on her scalp; She has broken out in a rash on the entire left side,; It is burning; Hurts; This spontaneous case was reported by a consumer and describes the occurrence of RASH (She has broken out in a rash on the entire left side,), SKIN BURNING SENSATION (It is burning), PAIN (Hurts), PRURITUS (Itching on her scalp) and URTICARIA (Little welts breaking out on the back of her neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced RASH (She has broken out in a rash on the entire left side,), SKIN BURNING SENSATION (It is burning) and PAIN (Hurts). On 26-Apr-2021, the patient experienced PRURITUS (Itching on her scalp) and URTICARIA (She has one right in the center of her throat and a few in the middle of her chest). On 28-Apr-2021, the patient experienced URTICARIA (Little welts breaking out on the back of her neck). At the time of the report, RASH (She has broken out in a rash on the entire left side,), SKIN BURNING SENSATION (It is burning), PAIN (Hurts), PRURITUS (Itching on her scalp), URTICARIA (Little welts breaking out on the back of her neck) and URTICARIA (She has one right in the center of her throat and a few in the middle of her chest) outcome was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fall, Influenza like illness
Clinical narrative: Got Flu like symptoms; Felt extremly dizzy; Fell at night; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Got Flu like symptoms), DIZZINESS (Felt extremly dizzy) and FALL (Fell at night) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and unknown) for COVID-19 vaccination.     No Medical history was provided by the reporter.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Got Flu like symptoms), DIZZINESS (Felt extremly dizzy) and FALL (Fell at night). On 20-Feb-2021, INFLUENZA LIKE ILLNESS (Got Flu like symptoms), DIZZINESS (Felt extremly dizzy) and FALL (Fell at night) had resolved.            No relevant concomitant medications reported. Treatment details included OTC medications.   This case was linked to MOD-2021-025792, MOD-2021-027818 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: From time to time she feels pain in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (From time to time she feels pain in her arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025l20a) for COVID-19 vaccination.     No medical history was reported.     On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (From time to time she feels pain in her arm). At the time of the report, PAIN IN EXTREMITY (From time to time she feels pain in her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30-MAY-2021 . No new information
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Pain in extremity, Product administered to patient of inappropriate age, Skin exfoliation
Clinical narrative: scaly and darker red armpit; scaly and darker red armpit; like a bruise; 16-year-old daughter accidentally received the Moderna vaccine; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old daughter accidentally received the Moderna vaccine), PAIN IN EXTREMITY (arm soreness), ERYTHEMA (scaly and darker red armpit), SKIN EXFOLIATION (scaly and darker red armpit) and CONTUSION (like a bruise) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old daughter accidentally received the Moderna vaccine) and PAIN IN EXTREMITY (arm soreness). On 01-May-2021, the patient experienced ERYTHEMA (scaly and darker red armpit), SKIN EXFOLIATION (scaly and darker red armpit) and CONTUSION (like a bruise). On 29-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-year-old daughter accidentally received the Moderna vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness), ERYTHEMA (scaly and darker red armpit), SKIN EXFOLIATION (scaly and darker red armpit) and CONTUSION (like a bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took acetaminophen.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD21-085288 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up information received on 03 May 2021. Date of birth was added, patient's age was updated, anatomical location for vaccine was added, 4 new events were added.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. MOD21-085288:significant follow up
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Illness, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: Ear ache; arm swelling; arm soreness; Tachycardia; felt lousy; flu-like muscle soreness; This spontaneous case was reported by a nurse and describes the occurrence of TACHYCARDIA (Tachycardia), ILLNESS (felt lousy), PERIPHERAL SWELLING (arm swelling), PAIN IN EXTREMITY (arm soreness) and EAR PAIN (Ear ache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Hepatitis: Hepatitis vaccines (Patient reported tachycardia post hepatitis vaccines.); for Flu: Flu vaccine (Patient reported tachycardia post flu vaccine.). Past adverse reactions to the above products included Tachycardia with Flu vaccine and Hepatitis vaccines. Concurrent medical conditions included Mitral valve prolapse and Anxiety (Due to anxiety from episode, patient also experiences a strong loss of appetite that evening.). Concomitant products included METOPROLOL for Mitral valve prolapse, METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (AMLODIPINE [AMLODIPINE BESILATE]), ESCITALOPRAM OXALATE (LEXAPRO), OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), HYDRALAZINE and MIRTAZAPINE for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced TACHYCARDIA (Tachycardia), ILLNESS (felt lousy) and MYALGIA (flu-like muscle soreness). On 01-May-2021, the patient experienced PERIPHERAL SWELLING (arm swelling) and PAIN IN EXTREMITY (arm soreness). On 02-May-2021, the patient experienced EAR PAIN (Ear ache). On 30-Apr-2021, TACHYCARDIA (Tachycardia) had resolved. On 01-May-2021, ILLNESS (felt lousy) and MYALGIA (flu-like muscle soreness) had resolved. At the time of the report, PERIPHERAL SWELLING (arm swelling) and PAIN IN EXTREMITY (arm soreness) was resolving and EAR PAIN (Ear ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included rest, ice on arm and metoprolol for tachycardia.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Ear ache; arm swelling; arm soreness; Tachycardia; felt lousy; flu-like muscle soreness; This spontaneous case was reported by a nurse and describes the occurrence of TACHYCARDIA (Tachycardia), ILLNESS (felt lousy), PERIPHERAL SWELLING (arm swelling), PAIN IN EXTREMITY (arm soreness) and EAR PAIN (Ear ache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Hepatitis: Hepatitis vaccines (Patient reported tachycardia post hepatitis vaccines.); for Flu: Flu vaccine (Patient reported tachycardia post flu vaccine.). Past adverse reactions to the above products included Tachycardia with Flu vaccine and Hepatitis vaccines. Concurrent medical conditions included Mitral valve prolapse and Anxiety (Due to anxiety from episode, patient also experiences a strong loss of appetite that evening.). Concomitant products included METOPROLOL for Mitral valve prolapse, METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (AMLODIPINE [AMLODIPINE BESILATE]), ESCITALOPRAM OXALATE (LEXAPRO), OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), HYDRALAZINE and MIRTAZAPINE for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced TACHYCARDIA (Tachycardia), ILLNESS (felt lousy) and MYALGIA (flu-like muscle soreness). On 01-May-2021, the patient experienced PERIPHERAL SWELLING (arm swelling) and PAIN IN EXTREMITY (arm soreness). On 02-May-2021, the patient experienced EAR PAIN (Ear ache). On 30-Apr-2021, TACHYCARDIA (Tachycardia) had resolved. On 01-May-2021, ILLNESS (felt lousy) and MYALGIA (flu-like muscle soreness) had resolved. At the time of the report, PERIPHERAL SWELLING (arm swelling) and PAIN IN EXTREMITY (arm soreness) was resolving and EAR PAIN (Ear ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included rest, ice on arm and metoprolol for tachycardia.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Vaccination site nodule
Clinical narrative: redness spread all on the upper arm; it was itching,; rash is now4 inches long and 2-3 inches wide and is spreading a little everyday; A knot appeared which is getting bigger and the size of a golf ball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (A knot appeared which is getting bigger and the size of a golf ball), ERYTHEMA (redness spread all on the upper arm), PRURITUS (it was itching,) and RASH (rash is now4 inches long and 2-3 inches wide and is spreading a little everyday) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE NODULE (A knot appeared which is getting bigger and the size of a golf ball). On 25-Apr-2021, the patient experienced ERYTHEMA (redness spread all on the upper arm), PRURITUS (it was itching,) and RASH (rash is now4 inches long and 2-3 inches wide and is spreading a little everyday). At the time of the report, VACCINATION SITE NODULE (A knot appeared which is getting bigger and the size of a golf ball), ERYTHEMA (redness spread all on the upper arm), PRURITUS (it was itching,) and RASH (rash is now4 inches long and 2-3 inches wide and is spreading a little everyday) outcome was unknown.            No concomitant medications were reported. Patient did not take any treatment.   This case was linked to MOD-2021-101563 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up information received on 22 Jul 2021 contains no new information.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site discomfort
Clinical narrative: Little discomfort on patient's arm at injection site after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Little discomfort on patient's arm at injection site after first dose) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 004621A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE DISCOMFORT (Little discomfort on patient's arm at injection site after first dose). On 01-Apr-2021, VACCINATION SITE DISCOMFORT (Little discomfort on patient's arm at injection site after first dose) had resolved.            Patient reported that for first dose the sticker from the vial was peeled off and put on the card by the vaccination provider for documentation of the first dose of vaccine administration. Patient also reported that after the first dose the vaccination provider gave record card with time stamp for the time he had to sit for 15 minutes before he can leave. No concomitant medications were reported. No treatment medications were reported.